Biomaterials Market Research Report – Forecast till 2027

Biomaterials Market Information: By Type (Metallic, Ceramics, Polymeric, Natural Biomaterials), by Application (Joint Replacements, Ophthalmology, Cardiovascular, Wound Healing, Plastic Surgery, Neurological Conditions, and Others) - Forecast till 2027

ID: MRFR/CnM/1489-HCR | February 2021 | Region: Global | 100 pages

Biomaterials Market Scenario



Biomaterials Market Size is anticipated to surpass of CAGR 12% by 2023, as reported in the latest study by Market Research Future.


Biomaterials are material of natural or synthetic origin and can be used as implants to substitute any damaged organ or tissue to improve its functionality. The Biomaterials Market is fueled by factors such as rise in prevalence of cardiovascular diseases, growing demand for implantable devices, increasing wound healing therapies, rising geriatric population, superior properties of biomaterials, increasing awareness of regenerative medicine, increasing orthopedic disorders, and increasing funds by the government for research purposes.


Furthermore, biomaterials science can be implemented in various advanced medical technologies such as tissue engineering, plastic surgery, drug delivery devices, and other medical implants. Biomaterial applications are finding prominence in the research on biomedical engineering, biomineralization, and biomolecules.

List of Key Players in the Biomaterials Market


Some major players in the Biomaterials Market include



  • Royal DSM (Netherlands),

  • BASF SE (Germany),

  • Corbion N.V. (Netherlands),

  • Covestro (Germany),

  • Invibio Ltd. (U.K.),

  • Carpenter Technology Corporation (U.S.),

  • Evonik Industries AG (Germany),

  • Berkeley Advanced Biomaterials, Inc. (U.S.),

  • CAM Bioceramics BV (Netherlands),

  • Celanese Corporation (U.S.),

  • Wright Medical Technology, Inc. (U.S.),

  • Zimmer Biomet Holdings, Inc. (U.S.),

  • Bayer AG (Germany),  

  • Collagen Matrix (U.S.).



Segmentation


The Biomaterials Market is segmented on the basis of Type and Application.


On the basis of the Type, the Biomaterials Market is segmented into metallic, ceramics, polymeric, natural biomaterials, and others. The metallic segment is divided into stainless steel, titanium & titanium alloys, cobalt-chrome alloys, silver, gold, and magnesium. The ceramics segment is divided into calcium phosphate, aluminum oxide, zirconia, calcium sulfate, carbon, and glass. The polymeric segment is further divided into polymethylmethacrylate (PMMA), polyethylene, polyester, polyvinyl chloride, silicone rubber, nylon, polyetheretherketone (PEEK), polylactic acid, poly glycolic acid, and poly(lactide-coglycolide), and others. The natural biomaterials is further segmented into hyaluronic acid, collagen, gelatin, fibrin, cellulose, chitin, alginate, and silk


On the basis of the Application, the Biomaterials Market is classified into cardiovascular, orthopedic, ophthalmology, dental, plastic surgery, wound healing, tissue engineering, neurological disorders, and others


The cardiovascular segment is divided into catheters, stents, implantable cardiac defibrillators, pacemakers, sensors, heart valves, vascular grafts, guidewires, and others.


The orthopedic is divided into joint replacement, viscosupplementation, bioresorbable tissue fixation, spine, fracture fixation devices, and orthobiologics. The joint replacement is further divided into knee replacement, hip replacement, shoulder replacement, and others.

The bioresorbable tissue fixation is divided into suture anchors, interference screws, meniscal repair tacks, and meshes. The spine segment is divided into spinal fusion, minimally invasive fusion surgery, and motion preservation. The fracture fixation devices are divided into bone plates, screws, pins, rods, and wires.


The ophthalmology is further divided into contact lens, intraocular lens, functional replacements of ocular tissues, synthetic corneas, and others. The dental segment is further divided into dental implants, dental bone grafts & substitutes, dental membranes, and tissue regeneration materials. The plastic surgery is divided into soft tissue fillers and craniofacial surgery. The wound healing is categorized into wound closure devices, adhesion barriers, surgical hemostats, internal tissue sealants, and hernia meshes. The tissue engineering segment is divided into scaffolds for regenerative medicine, nanomaterials for biosensing, tailoring of inorganic nanoparticles. The neurological disorders segment is divided into shunting systems, cortical neural prosthetics, hydrogel scaffolds for CNS repair, neural stem cell encapsulation


Research Methodology Biomaterial Market
Sources: Annual reports, Press release, White paper, and Company presentation


Regional Analysis


The Biomaterials Market consists of countries namely the Americas, Europe, Asia Pacific, and the Middle East.


The Americas dominate the Biomaterials Market owing to the increasing healthcare expenditure followed by Europe and Asia Pacific. According to the American Heart Association, the death due to cardiovascular diseases accounted for more than 800,000 in the U.S. Approximately 2,200 Americans die of cardiovascular disease each day. This increase in death ratio in North America is expected to drive the demand for biomaterials based cardiovascular systems. Europe holds the second position in the global biomaterials market owing to the government support for research & development and availability of funds for research.


Asia Pacific is the fastest growing region owing to the increasing obesity, introduction of biomaterials in cancer research, and rising patient awareness and improved lifestyle in growing economies such as India, China, and Brazil are expected to create opportunities in the biomaterials market. Additionally, the region has the highest potential to grow in the forecast period due to the presence of emerging economies such as China and India.


The Middle East & Africa holds the least share of the Biomaterials Market owing to less availability of funds, limited medical facilities, and deprived political conditions in Africa.


Industry News

October 2021- Bucha Bio has sealed a round of funding with USD550,000 to support the company produce its bio textile solution a reality. The round has witnessed several VCs, including New Climate Ventures, Lifely, and MicroVentures, among several others, and angel investors Cary Pinkowski, Fiona and George Sobek, and Nicholas Valeriano. Moving from the round will aid Bucha to scale its flagship luxury bio textile, Mirai. It’s made from substantially renewable bacterial-nanocellulose and could relocate plastic-based and animal-based leathers.

In partnership with DuPont Biomaterials, October 2021- Part of Welspun Group, Welspun India has launched a latest home textile collection, including bed sheets and bath towels, made with bio-based materials to meet the increasing demand for sustainable home textile products. The partnerships get together cotton and DuPont Sorona fibers to make home textile fabrics. The fabrics utilized in the latest range offer a luxurious drape, moisture management, comfort, and a soft, smooth, and hand feel, stated both the companies in a joint press release.


July 13, 2019: In Spain, there will be a process of incorporating seven new biomaterials. In the latest, REGEMAT 3D will launch a catalog of biomaterials that customers can buy and use along with their bioprinting systems. In recent years, advances in 3D bioprinting systems have become very important, as well as new biomaterials for regenerative medicine.


December 2020: Zimmer Biomet Holdings, a renowned name in musculoskeletal healthcare, has announced that the company has accomplished the acquisition of A&E Medical Corporation, a prominent company manufacturing medical devices, for USD 15 million.


Intended Audience



  • Biomaterials manufacturing companies

  • Original equipment manufacturing companies

  • Suppliers and distributors of biomaterials

  • Healthcare service providers

  • Teaching hospitals and academic medical centers (AMCs)

  • Health insurance players

  • Research and consulting firms

  • Medical research institutes

  • Venture capitalists

  • Community Centers



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant value
  CAGR   12%(2019–2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   By Type, Application and Region
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Royal DSM (Netherlands), BASF SE (Germany), Corbion N.V. (Netherlands), Covestro (Germany), Invibio Ltd. (U.K.), Carpenter Technology Corporation (U.S.), Evonik Industries AG (Germany), Berkeley Advanced Biomaterials, Inc. (U.S.), CAM Bioceramics BV (Netherlands), and Celanese Corporation (U.S.), Wright Medical Technology, Inc. (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Bayer AG (Germany), Collagen Matrix (U.S.).
  Key Market Opportunities   Increasing orthopedic disorders, and increasing funds by the government for research purposes.
  Key Market Drivers

  • Rise in prevalence of cardiovascular diseases
  • Growing demand for implantable devices Increasing wound healing therapies

    		•


    Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    The biomaterials market would attain 12% CAGR between 2020 and 2027, the forecast period.

    Factors like the rise in cardiovascular diseases, increasing wound healing therapies, booming geriatric population, surging demand for implantable devices, increasing awareness of regenerative medicine, superior properties of biomaterials, various orthopedic disorders, and increasing funds for R&D can influence the growth of the biomaterials market.

    The Americas is slated to dominate the biomaterials market.

    Prominent names to inspire influence in the biomaterials market are BASF SE (Germany), Royal DSM (Netherlands), Covestro (Germany), Corbion N.V. (Netherlands), Carpenter Technology Corporation (U.S.), Invibio Ltd. (U.K.), Berkeley Advanced Biomaterials, Inc. (U.S.), CAM Bioceramics BV (Netherlands), Evonik Industries AG (Germany), Celanese Corporation (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Bayer AG (Germany), Wright Medical Technology, Inc. (U.S.), Collagen Matrix (U.S.), and others.

    Advertising, mergers, better R&D, product launch, collaborations, acquisitions, and other tactical changes are going to be implemented by the players involved in the biomaterials market.

    TABLE OF CONTENT

    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary research

    3.4 Market Size Estimation

    Chapter 4. Market Dynamics

    4.1 Drivers

    4.2 Restrains

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    Chapter 5. Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    Chapter 6. Global Biomaterials Market, by Type

    6.1 Introduction

    6.2 Metallic

    6.2.1 Market Estimates & Forecast, 2020 – 2027

    6.2.2 Stainless Steel

    6.2.2.1 Market Estimates & Forecast, 2020 – 2027

    6.2.3 Titanium & Titanium Alloys

    6.2.3.1 Market Estimates & Forecast, 2020 – 2027

    6.2.4 Cobalt-Chrome Alloys

    6.2.4.1 Market Estimates & Forecast, 2020 – 2027

    6.2.5 Silver

    6.2.5.1 Market Estimates & Forecast, 2020 – 2027

    6.2.6 Gold

    6.2.6.1 Market Estimates & Forecast, 2020 – 2027

    6.2.7 Magnesium

    6.2.7.1 Market Estimates & Forecast, 2020 – 2027

    6.3 Ceramic

    6.3.1 Market Estimates & Forecast, 2020 – 2027

    6.3.2 Calcium Phosphate

    6.3.2.1 Market Estimates & Forecast, 2020 – 2027

    6.3.3 Aluminum Oxide

    6.3.3.1 Market Estimates & Forecast, 2020 – 2027

    6.3.4 Zirconia

    6.3.4.1 Market Estimates & Forecast, 2020 – 2027

    6.3.5 Calcium Sulfate

    6.3.5.1 Market Estimates & Forecast, 2020 – 2027

    6.3.6 Carbon

    6.3.6.1 Market Estimates & Forecast, 2020 – 2027

    6.3.7 Glass

    6.3.7.1 Market Estimates & Forecast, 2020 – 2027

    6.4 Polymeric

    6.4.1 Market Estimates & Forecast, 2020 – 2027

    6.4.2 Polymethylmethacrylate (PMMA)

    6.4.2.1 Market Estimates & Forecast, 2020 – 2027

    6.4.3 Polyethylene

    6.4.3.1 Market Estimates & Forecast, 2020 – 2027

    6.4.4 Polyester

    6.4.4.1 Market Estimates & Forecast, 2020 – 2027

    6.4.5 Polyvinyl Chloride

    6.4.5.1 Market Estimates & Forecast, 2020 – 2027

    6.4.6 Silicone Rubber

    6.4.6.1 Market Estimates & Forecast, 2020 – 2027

    6.4.7 Nylon

    6.4.7.1 Market Estimates & Forecast, 2020 – 2027

    6.4.8 Polyetheretherketone (PEEK)

    6.4.8.1 Market Estimates & Forecast, 2020 – 2027

    6.4.9 Polylactic Acid

    6.4.9.1 Market Estimates & Forecast, 2020 – 2027

    6.4.10 Others

    6.5 Natural Biomaterials

    6.5.1 Market Estimates & Forecast, 2020 – 2027

    6.5.2 Hyaluronic Acid

    6.5.2.1 Market Estimates & Forecast, 2020 – 2027

    6.5.3 Collagen

    6.5.3.1 Market Estimates & Forecast, 2020 – 2027

    6.5.4 Gelatin

    6.5.4.1 Market Estimates & Forecast, 2020 – 2027

    6.5.5 Fibrin

    6.5.5.1 Market Estimates & Forecast, 2020 – 2027

    6.5.6 Cellulose

    6.5.6.1 Market Estimates & Forecast, 2020 – 2027

    6.5.7 Chitin

    6.5.7.1 Market Estimates & Forecast, 2020 – 2027

    6.5.8 Alginate

    6.5.8.1 Market Estimates & Forecast, 2020 – 2027

    6.5.8 Silk

    6.5.8.1 Market Estimates & Forecast, 2020 – 2027

    6.6 Others

    Chapter 7. Global Biomaterials Market, by Application

    7.1 Introduction

    7.2 Cardiovascular

    7.2.1 Market Estimates & Forecast, 2020 – 2027

    7.2.2 Catheters

    7.2.2.1 Market Estimates & Forecast, 2020 – 2027

    7.2.3 Stents

    7.2.3.1 Market Estimates & Forecast, 2020 – 2027

    7.2.4 Implantable Cardiac Defibrillators

    7.2.4.1 Market Estimates & Forecast, 2020 – 2027

    7.2.5 Pacemakers

    7.2.5.1 Market Estimates & Forecast, 2020 – 2027

    7.2.6 Sensors

    7.2.6.1 Market Estimates & Forecast, 2020 – 2027

    7.2.7 Heart Valves

    7.2.7.1 Market Estimates & Forecast, 2020 – 2027

    7.2.8 Vascular Grafts

    7.2.8.1 Market Estimates & Forecast, 2020 – 2027

    7.2.9 Guidewires

    7.2.9.1 Market Estimates & Forecast, 2020 – 2027

    7.2.10 Others

    7.3 Orthopedic

    7.3.1 Market Estimates & Forecast, 2020 – 2027

    7.3.2 Joint Replacement

    7.3.2.1 Market Estimates & Forecast, 2020 – 2027

    7.3.2.2 Knee Replacement

    7.3.2.2.1 Market Estimates & Forecast, 2020 – 2027

    7.3.2.3 Hip Replacement

    7.3.2.3.1 Market Estimates & Forecast, 2020 – 2027

    7.3.2.4 Shoulder Replacement

    7.3.2.4.1 Market Estimates & Forecast, 2020 – 2027

    7.3.2.5 Others

    7.3.3 Viscosupplementation

    7.3.3.1 Market Estimates & Forecast, 2020 – 2027

    7.3.4 Bioresorbable Tissue Fixation

    7.3.4.1 Market Estimates & Forecast, 2020 – 2027

    7.3.4.2 Suture Anchors

    7.3.4.2.1 Market Estimates & Forecast, 2020 – 2027

    7.3.4.3 Interference Screws

    7.3.4.3.1 Market Estimates & Forecast, 2020 – 2027

    7.3.4.4 Meniscal Repair Tacks

    7.3.4.4.1 Market Estimates & Forecast, 2020 – 2027

    7.3.4.5 Meshes

    7.3.4.5.1 Market Estimates & Forecast, 2020 – 2027

    7.3.5 Spine

    7.3.5.1 Market Estimates & Forecast, 2020 – 2027

    7.3.5.2 Spinal Fusion

    7.3.5.2.1 Market Estimates & Forecast, 2020 – 2027

    7.3.5.3 Minimally Invasive Fusion Surgery

    7.3.5.3.1 Market Estimates & Forecast, 2020 – 2027

    7.3.5.4 Motion Preservation

    7.3.5.4.1 Market Estimates & Forecast, 2020 – 2027

    7.3.6 Fracture Fixation Devices

    7.3.6.1 Market Estimates & Forecast, 2020 – 2027

    7.3.6.2 Bone Plates

    7.3.6.2.1 Market Estimates & Forecast, 2020 – 2027

    7.3.6.3 Screws

    7.3.6.3.1 Market Estimates & Forecast, 2020 – 2027

    7.3.6.4 Pins

    7.3.6.4.1 Market Estimates & Forecast, 2020 – 2027

    7.3.6.5 Rods

    7.3.6.2.1 Market Estimates & Forecast, 2020 – 2027

    7.3.6.6 Wires

    7.3.6.3.1 Market Estimates & Forecast, 2020 – 2027

    7.3.7 Orthobiologics

    7.3.7.1 Market Estimates & Forecast, 2020 – 2027

    7.4 Ophthalmology

    7.4.1 Market Estimates & Forecast, 2020 – 2027

    7.4.2 Contact Lens

    7.4.2.1 Market Estimates & Forecast, 2020 – 2027

    7.4.3 Intraocular Lens

    7.4.3.1 Market Estimates & Forecast, 2020 – 2027

    7.4.4 Functional Replacements of Ocular Tissues

    7.4.4.1 Market Estimates & Forecast, 2020 – 2027

    7.4.5 Synthetic Corneas

    7.4.5.1 Market Estimates & Forecast, 2020 – 2027

    7.4.6 Others

    7.5 Dental

    7.5.1 Market Estimates & Forecast, 2020 – 2027

    7.5.2 Dental Implants

    7.5.2.1 Market Estimates & Forecast, 2020 – 2027

    7.5.3 Dental Bone Grafts & Substitutes

    7.5.3.1 Market Estimates & Forecast, 2020 – 2027

    7.5.4 Dental Membranes

    7.5.4.1 Market Estimates & Forecast, 2020 – 2027

    7.5.5 Tissue Regeneration Materials

    7.5.5.1 Market Estimates & Forecast, 2020 – 2027

    7.6 Plastic Surgery

    7.6.1 Market Estimates & Forecast, 2020 – 2027

    7.6.2 Soft Tissue Fillers

    7.6.2.1 Market Estimates & Forecast, 2020 – 2027

    7.6.3 Craniofacial Surgery

    7.6.3.1 Market Estimates & Forecast, 2020 – 2027

    7.7 Wound Healing

    7.7.1 Market Estimates & Forecast, 2020 – 2027

    7.7.2 Wound Closure Devices

    7.7.2.1 Market Estimates & Forecast, 2020 – 2027

    7.7.3 Adhesion Barriers

    7.7.3.1 Market Estimates & Forecast, 2020 – 2027

    7.7.4 Surgical Hemostats

    7.7.4.1 Market Estimates & Forecast, 2020 – 2027

    7.7.5 Internal Tissue Sealants

    7.7.5.1 Market Estimates & Forecast, 2020 – 2027

    7.7.6 Hernia Meshes

    7.7.6.1 Market Estimates & Forecast, 2020 – 2027

    7.8 Tissue Engineering

    7.8.1 Market Estimates & Forecast, 2020 – 2027

    7.8.2 Scaffolds for Regenerative Medicine

    7.8.2.1 Market Estimates & Forecast, 2020 – 2027

    7.8.3 Nanomaterials for Biosensing

    7.8.3.1 Market Estimates & Forecast, 2020 – 2027

    7.8.4 Tailoring of Inorganic Nanoparticles

    7.8.4.1 Market Estimates & Forecast, 2020 – 2027

    7.9 Neurological Disorders

    7.9.1 Market Estimates & Forecast, 2020 – 2027

    7.9.2 Shunting Systems

    7.9.2.1 Market Estimates & Forecast, 2020 – 2027

    7.9.3 Cortical Neural Prosthetics

    7.9.3.1 Market Estimates & Forecast, 2020 – 2027

    7.9.4 Hydrogel Scaffolds for CNS Repair

    7.9.4.1 Market Estimates & Forecast, 2020 – 2027

    7.9.5 Neural Stem Cell Encapsulation

    7.9.5.1 Market Estimates & Forecast, 2020 – 2027

    7.10 Others

    Chapter .8 Global Biomaterials Market, by Region

    8.1 Introduction

    8.2 Americas

    8.2.1 North America

    8.2.1.1 U.S.

    8.2.1.2 Canada

    8.2.2 South America

    8.3 Europe

    8.3.1 Western Europe

    8.3.1.1 Germany

    8.3.1.2 France

    8.3.1.3 Italy

    8.3.1.4 Spain

    8.3.1.5 U.K

    8.3.1.6 Rest of Western Europe

    8.3.2 Eastern Europe

    8.4 Asia Pacific

    8.4.1 Japan

    8.4.2 China

    8.4.3 India

    8.4.4 Australia

    8.4.5 Republic of Korea

    8.4.6 Rest of Asia Pacific

    8.5 The Middle East & Africa

    8.5.1 United Arab Emirates

    8.5.2 Saudi Arabia

    8.5.3 Oman

    8.5.4 Kuwait

    8.5.5 Qatar

    8.5.6 Rest of the Middle East & Africa

    Chapter 9 Company Landscape

    9.1 Introduction

    9.2 Market Share Analysis

    9.3 Key Development & Strategies

    9.3.1 Key Developments

    Chapter 10 Company Profiles

    10.1 Royal DSM

    10.1.1 Company Overview

    10.1.2 Product Overview

    10.1.3 Financials

    10.1.4 SWOT Analysis

    10.2 BASF SE

    10.2.1 Company Overview

    10.2.2 Product Overview

    10.2.3 Financial Overview

    10.2.4 Key Developments

    10.2.5 SWOT Analysis

    10.3 Corbion N.V.

    10.3.1 Company Overview

    10.3.2 Product Overview

    10.3.3 Financial Overview

    10.3.4 Key Development

    10.3.5 SWOT Analysis

    10.4 Covestro

    10.4.1 Company Overview

    10.4.2 Product/Business Segment Overview

    10.4.3 Financial Overview

    10.4.4 Key Development

    10.4.5 SWOT Analysis

    10.5 Invibio Ltd.

    10.5.1 Company Overview

    10.5.2 Product Overview

    10.5.3 Financial overview

    10.5.4 Key Developments

    10.6 Carpenter Technology Corporation

    10.6.1 Company Overview

    10.6.2 Product Overview

    10.6.3 Financial Overview

    10.6.4 Key Developments

    10.7 Evonik Industries AG

    10.7.1 Overview

    10.7.2 Product Overview

    10.7.3 Financials

    10.7.4 Key Developments

    10.7.5 SWOT Analysis

    10.8 Berkeley Advanced Biomaterials, Inc.

    10.8.1 Company Overview

    10.8.2 Product/Business Segment Overview

    10.8.3 Financial Overview

    10.8.4 Key Development

    10.8.5 SWOT Analysis

    10.9 CAM Bioceramics BV

    10.9.1 Company Overview

    10.9.2 Product Overview

    10.9.3 Financial overview

    10.9.4 Key Developments

    10.10 Celanese Corporation

    10.10.1 Company Overview

    10.10.2 Product Overview

    10.10.3 Financial overview

    10.10.4 Key Developments

    10.11 Others

    Chapter 11 MRFR Conclusion

    11.1 Key Findings

    11.1.1 From CEO’s View Point

    11.1.2 Unmet Needs of the Market

    11.2 Key Companies to Watch

    11.3 Prediction of Pharmaceutical industry

    Chapter 12 Appendix

    LIST OF TABLES

    Table 1 Biomaterials Industry Synopsis, 2020 – 2027

    Table 2 Biomaterials Market Estimates and Forecast, 2020 – 2027, (USD Million)

    Table 3 Biomaterials Market by Region, 2020 – 2027, (USD Million)

    Table 4 Biomaterials Market by Type, 2020 – 2027, (USD Million)

    Table 5 Biomaterials Market by Application, 2020 – 2027, (USD Million)

    Table 6 Biomaterials Market by End Users, 2020 – 2027, (USD Million)

    Table 7 North America Biomaterials Market by Type, 2020 – 2027, (USD Million)

    Table 8 North America Biomaterials Market by Application, 2020 – 2027, (USD Million)

    Table 9 US Biomaterials Market by Type, 2020 – 2027, (USD Million)

    Table 10 US Biomaterials Market by Application, 2020 – 2027, (USD Million)

    Table 11 Canada Biomaterials Market by Type, 2020 – 2027, (USD Million)

    Table 12 Canada Biomaterials Market by Application, 2020 – 2027, (USD Million)

    Table 13 South America Biomaterials Market by Type, 2020 – 2027, (USD Million)

    Table 14 South America Biomaterials Market by Application, 2020 – 2027, (USD Million)

    Table 15 Europe Biomaterials Market by Type, 2020 – 2027, (USD Million)

    Table 16 Europe Biomaterials Market by Application, 2020 – 2027, (USD Million)

    Table 17 Western Europe Biomaterials Market by Type, 2020 – 2027, (USD Million)

    Table 18 Western Europe Biomaterials Market by Application, 2020 – 2027, (USD Million)

    Table 19 Eastern Europe Biomaterials Market by Type, 2020 – 2027, (USD Million)

    Table 20 Eastern Europe Biomaterials Market by Application, 2020 – 2027, (USD Million)

    Table 21 Asia Pacific Biomaterials Market by Type, 2020 – 2027, (USD Million)

    Table 22 Asia Pacific Biomaterials Market by Application, 2020 – 2027, (USD Million)

    Table 23 Middle East & Africa Biomaterials Market by Type, 2020 – 2027, (USD Million)

    Table 24 Middle East & Africa Biomaterials Market by Application, 2020 – 2027, (USD Million)

    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Biomaterials Market

    Figure 3 Segmentation Market Dynamics for Biomaterials Market

    Figure 4 Global Biomaterials Market Share, by Type 2020

    Figure 5 Global Biomaterials Market Share, by Application 2020

    Figure 6 Global Biomaterials Market Share, by Region, 2020

    Figure 7 Americas Biomaterials Market Share, by Country, 2020

    Figure 8 Europe Biomaterials Market Share, by Country, 2020

    Figure 9 Asia Pacific Biomaterials Market Share, by Country, 2020

    Figure 10 Middle East & Africa Biomaterials Market Share, by Country, 2020

    Figure 11 Global Biomaterials Market: Company Share Analysis, 2020 (%)

    Figure 12 Royal DSM: Key Financials

    Figure 13 Royal DSM: Segmental Revenue

    Figure 14 Royal DSM: Geographical Revenue

    Figure 15 BASF SE: Key Financials

    Figure 16 BASF SE: Segmental Revenue

    Figure 17 BASF SE: Geographical Revenue

    Figure 18 Corbion N.V.: Key Financials

    Figure 19 Corbion N.V.: Segmental Revenue

    Figure 20 Corbion N.V.: Geographical Revenue

    Figure 21 Covestro: Key Financials

    Figure 22 Covestro: Segmental Revenue

    Figure 23 Covestro: Geographical Revenue

    Figure 24 Invibio Ltd.: Key Financials

    Figure 25 Invibio Ltd.: Segmental Revenue

    Figure 26 Invibio Ltd.: Geographical Revenue

    Figure 27 Carpenter Technology Corporation: Key Financials

    Figure 28 Carpenter Technology Corporation: Segmental Revenue

    Figure 29 Carpenter Technology Corporation: Geographical Revenue

    Figure 30 Evonik Industries AG: Key Financials

    Figure 31 Evonik Industries AG: Segmental Revenue

    Figure 32 Evonik Industries AG: Geographical Revenue

    Figure 33 Berkeley Advanced Biomaterials, Inc.: Key Financials

    Figure 34 Berkeley Advanced Biomaterials, Inc.: Segmental Revenue

    Figure 35 Berkeley Advanced Biomaterials, Inc.: Geographical Revenue

    Figure 36 CAM Bioceramics BV: Key Financials

    Figure 37 CAM Bioceramics BV: Segmental Revenue

    Figure 38 CAM Bioceramics BV: Geographical Revenue